Liquidia (LQDA) Competitors

Liquidia (NASDAQ:LQDA) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, community ranking, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.

Do analysts rate LQDA or INSP?

Liquidia presently has a consensus target price of $26.63, suggesting a potential upside of 106.40%. Inspire Medical Systems has a consensus target price of $226.70, suggesting a potential upside of 60.23%. Given Liquidia's stronger consensus rating and higher possible upside, equities research analysts plainly believe Liquidia is more favorable than Inspire Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Liquidia	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.11
Inspire Medical Systems	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70

Does the media prefer LQDA or INSP?

In the previous week, Inspire Medical Systems had 7 more articles in the media than Liquidia. MarketBeat recorded 12 mentions for Inspire Medical Systems and 5 mentions for Liquidia. Inspire Medical Systems' average media sentiment score of 1.67 beat Liquidia's score of 0.97 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Liquidia	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inspire Medical Systems	10 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do insiders and institutionals have more ownership in LQDA or INSP?

64.5% of Liquidia shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 30.1% of Liquidia shares are held by insiders. Comparatively, 4.1% of Inspire Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Which has preferable valuation and earnings, LQDA or INSP?

Inspire Medical Systems has higher revenue and earnings than Liquidia. Liquidia is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Liquidia	$14.00M	78.62	-$78.50M	-$1.67	-7.72
Inspire Medical Systems	$802.80M	5.24	$53.51M	$1.73	81.78

Which has more volatility and risk, LQDA or INSP?

Liquidia has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.39, meaning that its share price is 39% more volatile than the S&P 500.

Does the MarketBeat Community favor LQDA or INSP?

Liquidia received 13 more outperform votes than Inspire Medical Systems when rated by MarketBeat users. Likewise, 68.67% of users gave Liquidia an outperform vote while only 61.66% of users gave Inspire Medical Systems an outperform vote.

Company	Underperform	Outperform
Liquidia	Outperform Votes 206 68.67%	Underperform Votes 94 31.33%
Inspire Medical Systems	Outperform Votes 193 61.66%	Underperform Votes 120 38.34%

Is LQDA or INSP more profitable?

Inspire Medical Systems has a net margin of 6.67% compared to Liquidia's net margin of -765.38%. Inspire Medical Systems' return on equity of 8.19% beat Liquidia's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Liquidia	-765.38%	-163.21%	-67.14%
Inspire Medical Systems	6.67%	8.19%	7.09%

Summary

Inspire Medical Systems beats Liquidia on 12 of the 19 factors compared between the two stocks.